Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pharming Group N.V. Sponsored ADR (PHAR) had Return on Equity of 0.92% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$376.13M |
|
$2.85M |
|
$45.50M |
|
$330.63M |
|
$350.29M |
|
$25.84M |
|
$-13.00M |
|
$12.85M |
|
$12.85M |
|
$2.54M |
|
$2.54M |
|
$2.54M |
|
$2.54M |
|
$25.84M |
|
$37.06M |
|
68.88M |
|
74.69M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$299.47M |
|
$7.23M |
|
$200.49M |
|
$499.96M |
|
$115.79M |
|
$92.72M |
|
$107.07M |
|
$222.86M |
|
$277.10M |
|
$141.56M |
|
$277.10M |
|
70.17M |
|
| Cash Flow Statement Financials | |
$54.71M |
|
$26.25M |
|
$1.50M |
|
$54.94M |
|
$145.31M |
|
$90.36M |
|
$13.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
0.25 |
|
0.35 |
|
87.90% |
|
6.87% |
|
6.87% |
|
9.85% |
|
3.42% |
|
0.76% |
|
$53.96M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
0.70 |
|
6.88 |
|
53.08 |
|
|
Return on Equity |
0.92% |
1.79% |
|
0.51% |
|
0.69% |
|
$3.95 |
|
$0.72 |
|
$0.73 |
|